Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 22-Nov-24 7:48 PM View:  | Xenon Pharmaceuticals Inc. (XENE) | 22-Nov-24 | Payment of Exercise | 1,695 | $39.80 | $67,461.00 | (5%) 35.06K to 33.37K | |
| 22-Nov-24 7:48 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 22-Nov-24 | Option Exercise | 6,586 | $10.24 | $67,429.30 | 23% 28.48K to 35.06K | |
| 22-Nov-24 7:48 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 22-Nov-24 | Option Sale | 4,891 | $41.08 | $200,947.00 | (15%) 33.37K to 28.48K | |
| 15-Dec-23 5:38 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 13-Dec-23 | Payment of Exercise | 3,022 | $39.68 | $119,913.00 | (6%) 50.48K to 47.45K | |
| 15-Dec-23 5:38 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 13-Dec-23 | Option Exercise | 14,402 | $9.55 | $137,487.00 | 40% 36.07K to 50.48K | |
| 15-Dec-23 5:38 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 13-Dec-23 | Option Sale | 11,380 | $39.29 | $447,085.00 | (24%) 47.45K to 36.07K | |
| 15-Dec-23 5:38 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 13-Dec-23 | Option Sale | 3,022 | $41.05 | $124,053.00 | (8%) 36.07K to 33.05K | |
| 15-Dec-23 5:38 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 13-Dec-23 | Sale | 4,576 | $41.05 | $187,845.00 | (14%) 33.05K to 28.48K | |
| 28-Nov-22 8:41 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 25-Nov-22 | Payment of Exercise | 120 | $34.37 | $4,124.40 | (< 1%) 38.13K to 38.01K | |
| 28-Nov-22 8:41 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 25-Nov-22 | Option Exercise | 2,057 | $2.68 | $5,512.76 | 6% 36.07K to 38.13K | |
| 28-Nov-22 8:41 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 25-Nov-22 | Sale | 1,937 | $34.79 | $67,390.40 | (5%) 38.01K to 36.07K | |
| 28-Nov-22 8:41 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 23-Nov-22 | Private Option Sale | 2,057 | $34.33 | $70,609.60 | (5%) 38.13K to 36.07K | |
| 10-Dec-21 4:20 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 08-Dec-21 | Option Exercise | 2,057 | $3.67 | $7,549.19 | 6% 36.07K to 38.13K | |
| 04-Jun-21 7:20 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 17-Mar-21 | Acquisition (small) | 100 | $19.49 | $1,949.00 | < 1% 36.07K to 36.17K | (5%) |
| 29-Oct-20 4:20 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 28-Oct-20 | Option Exercise | 2,057 | $3.76 | $7,734.32 | 6% 34.02K to 36.07K | |
| 06-Dec-19 5:12 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 04-Dec-19 | Option Exercise | 2,057 | $3.56 | $7,322.92 | 6% 31.96K to 34.02K | |
| 18-Dec-18 4:06 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 14-Dec-18 | Option Exercise | 2,057 | $3.07 | $6,314.99 | 7% 29.9K to 31.96K | < 1% |
| 15-Jun-18 7:32 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 14-Jun-18 | Payment of Exercise | 2,856 | $8.30 | $23,704.80 | (9%) 32.76K to 29.9K | |
| 15-Jun-18 7:32 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 14-Jun-18 | Option Exercise | 8,230 | $3.70 | $30,451.00 | 34% 24.53K to 32.76K | |
| 14-Aug-17 6:07 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 10-Aug-17 | Market Purchase | 7,500 | $2.78 | $20,835.80 | 44% 17.03K to 24.53K | 106% |
| 10-Aug-17 7:58 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 08-Aug-17 | Market Purchase | 5,000 | $3.00 | $15,002.50 | 42% 12.03K to 17.03K | 91% |
| 08-Dec-16 4:52 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 06-Dec-16 | Payment of Exercise | 4,403 | $7.90 | $34,783.70 | (27%) 16.43K to 12.03K | |
| 08-Dec-16 4:52 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 06-Dec-16 | Option Exercise | 12,345 | $3.21 | $39,627.40 | 302% 4.09K to 16.43K | |
| 06-Nov-15 5:20 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 04-Nov-15 | Payment of Exercise | 1,955 | $8.32 | $16,265.60 | (32%) 6.04K to 4.09K | 8% |
| 06-Nov-15 5:20 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 04-Nov-15 | Option Exercise | 3,497 | $5.22 | $18,254.30 | 137% 2.54K to 6.04K | |
| 09-Jan-15 8:30 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 07-Jan-15 | Option Exercise | 3,497 | $4.98 | $17,415.10 | 100% 0 to 3.5K | |
| 08-Aug-14 4:31 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Aug-14 | Option Exercise | 20,000 | $10.16 | $203,258.00 | 2849% 0.7K to 20.7K | |
| 08-Aug-14 4:31 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Aug-14 | Market Option Sale (Planned) | 20,000 | $100.26 | $2,005,200.00 | (97%) 20.7K to 0.7K | 41% |
| 15-Jul-14 2:10 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 14-Jul-14 | Option Exercise | 30,000 | $6.47 | $194,007.00 | 7463% 0.4K to 30.4K | |
| 15-Jul-14 2:10 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 14-Jul-14 | Market Option Sale (Planned) | 29,700 | $86.96 | $2,582,640.00 | (98%) 30.4K to 0.7K | 32% |
| 13-May-14 6:46 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 12-May-14 | Option Exercise | 10,000 | $5.49 | $54,900.00 | 1424% 0.7K to 10.7K | |
| 13-May-14 6:46 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 12-May-14 | Market Option Sale (Planned) | 10,000 | $75.00 | $750,000.00 | (93%) 10.7K to 0.7K | 21% |
| 13-May-14 6:46 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 09-May-14 | Option Exercise | 20,000 | $2.94 | $58,723.70 | 2849% 0.7K to 20.7K | |
| 13-May-14 6:46 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 09-May-14 | Market Option Sale (Planned) | 20,000 | $74.08 | $1,481,600.00 | (97%) 20.7K to 0.7K | 20% |
| 12-Mar-14 4:58 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 11-Mar-14 | Acquisition (other) | 504 | -- | -- | 255% 0.2K to 0.7K | |
| 19-Nov-13 5:14 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 18-Nov-13 | Acquisition (other) | 83 | -- | -- | 72% 0.12K to 0.2K | |
| 04-Oct-13 4:57 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 01-Oct-13 | Option Exercise | 20,000 | $1.61 | $32,200.00 | 17391% 0.12K to 20.11K | |
| 04-Oct-13 4:57 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 01-Oct-13 | Market Option Sale (Planned) | 20,000 | $48.92 | $978,400.00 | (99%) 20.11K to 0.12K | (21%) |
| 02-Jul-13 4:47 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 02-Jul-13 | Option Exercise | 10,000 | $1.61 | $16,100.00 | 8696% 0.12K to 10.12K | |
| 02-Jul-13 4:47 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 02-Jul-13 | Market Option Sale (Planned) | 10,000 | $30.00 | $300,000.00 | (99%) 10.12K to 0.12K | (98%) |
| 02-Jul-13 4:47 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 01-Jul-13 | Option Exercise | 30,000 | $1.61 | $48,300.00 | 26087% 0.12K to 30.11K | |
| 02-Jul-13 4:47 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 01-Jul-13 | Market Option Sale (Planned) | 30,000 | $29.25 | $877,500.00 | (100%) 30.11K to 0.12K | (103%) |
| 16-Apr-13 2:49 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Apr-13 | Option Exercise | 10,000 | $1.61 | $16,100.00 | 8696% 0.12K to 10.12K | |
| 16-Apr-13 2:49 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Apr-13 | Market Option Sale (Planned) | 10,000 | $30.00 | $300,000.00 | (99%) 10.12K to 0.12K | (98%) |
| 03-Apr-13 12:53 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 01-Apr-13 | Option Exercise | 30,000 | $1.61 | $48,300.00 | 26087% 0.12K to 30.11K | |
| 03-Apr-13 12:53 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 01-Apr-13 | Market Option Sale (Planned) | 30,000 | $28.15 | $844,591.00 | (100%) 30.11K to 0.12K | (110%) |
| 13-Jun-08 6:07 PM View: | Oscient Pharmaceuticals Corp. (OSCI) | 12-Jun-08 | Grant | 300 | -- | -- | 2% 13.84K to 14.14K | |
| 08-Jun-07 6:42 PM View: | Oscient Pharmaceuticals Corp. (OSCI) | 07-Jun-07 | Grant | 300 | -- | -- | 2% 13.54K to 13.84K | |
| 12-Jun-06 10:00 PM View: | Oscient Pharmaceuticals Corp. (OSCI) | 08-Jun-06 | Grant | 2,400 | -- | -- | 2% 105.93K to 108.33K | |
| 02-Jun-06 5:12 PM View: | Oscient Pharmaceuticals Corp. (OSCI) | 31-May-06 | Market Sale | 20,000 | $1.26 | $25,200.00 | (16%) 125.93K to 105.93K | 98% |